Evidence map›Paper›PMID 18178098›Full record

ReviewCytokine2008

Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Fang Shen, Sarah L Gaffen

Open access · greenAbstract readReview
In one paragraph

Review in Cytokine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 1 synthesis or guideline pooled it, 249 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The IL-17 family in diseases: from bench to bedside.Signal transduction and targeted therapy · 2023
    Review
  10. Review
  11. The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Mechanisms of Corticosteroid Resistance in Type 17 Asthma.Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  17. Review
  18. Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells.International journal of molecular sciences · 2022
    Review
  19. Review
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Fang ShenDepartment of Oral Biology, School of Dental Medicine, University at Buffalo, State University of New York, Buffalo, NY, USA.
Sarah L Gaffen
University at Buffalo, State University of New York · US

Funding

Anti-Apoptotic Signaling by the IL-2/15 ReceptorR01AI049329 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI GAFFEN, SARAH L. · 2002 to 2006
$1.2M
Coinfection of Tick-borne Diseases in Areas of WisconsinR15AI043929 · NIAID · UNIVERSITY OF WISCONSIN STEVENS POINT · PI CAPORALE, DIANE A · 2001 to 2001
$92k
NIAID NIH HHS AI43929NIAID NIH HHS R01 AI049329NIAID NIH HHS R15 AI043929
6 · The paper itself

Abstract

IL-17 is the defining cytokine of a newly-described "Th17" population that plays critical roles in mediating inflammation and autoimmunity. The IL-17/IL-17 receptor superfamily is the most recent class of cytokines and receptors to be described, and until recently very little was known about its function or molecular biology. However, in the last year important new insights into the composition and dynamics of the receptor complex and mechanisms of downstream signal transduction have been made, which will be reviewed here.

Indexed as

AnimalsAntibodiesArthritis, RheumatoidBone RemodelingCCAAT-Enhancer-Binding ProteinsCytokinesHumansInflammation MediatorsInterleukin-6NF-kappa BProtein Structure, TertiaryReceptors, Interleukin-17Signal TransductionStructure-Activity RelationshipT-Lymphocytes, Helper-InducerTranscription FactorsAntibodiesCCAAT-Enhancer-Binding ProteinsCytokinesInflammation MediatorsInterleukin-6NF-kappa BReceptors, Interleukin-17Transcription Factors

Identifiers

PMID18178098
PMCPMC2667118
OpenAlexW2009438958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.